In this study, three CD8+ T cell‐related genes—CD52, CD69, and PLIN2—were identified as potential biomarkers for NSCLC, marking the first time these genes have been associated with the disease. This evidence concerns the gene PLIN2 and non-small cell lung carcinoma.